Correlation Between Eupraxia Pharmaceuticals and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Senti Biosciences, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Senti Biosciences.
Diversification Opportunities for Eupraxia Pharmaceuticals and Senti Biosciences
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eupraxia and Senti is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Senti Biosciences go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Senti Biosciences
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the Senti Biosciences. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals is 1.87 times less risky than Senti Biosciences. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Senti Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 292.00 in Senti Biosciences on September 1, 2024 and sell it today you would lose (76.00) from holding Senti Biosciences or give up 26.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 54.28% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Senti Biosciences
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Senti Biosciences |
Eupraxia Pharmaceuticals and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Senti Biosciences
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |